Product

Casirivimab and Imdevimab

1 clinical trial

1 indication

Indication

Clinical trial

Clinical Study to Evaluate the Possible Efficacy and Safety of Antibodies Combination (Casirivimab and Imdevimab) Versus Standard Antiviral Therapy (Remdesivir and Favipravir) as Antiviral Agent Against Corona Virus 2 Infection in Hospitalized COVID-19 Patients

Status: Completed, Estimated PCD: 2022-12-28